tirzepatide phase 1 Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, 3 trial Frontiers | Tirzepatide against obesity

Semaglutide and human reproduction: caution at the intersection of energy balance, ovarian function, and follicular development

Self-administering unlicensed or unregulated medicines obtained outside of legitimate healthcare channels carries significant safety risks and should be strongly discouraged

Consider reducing training frequency if you notice accumulating fatigue or declining performance despite adequate sleep

When to talk to a healthcare provider If you still feel very hungry or notice consistent cravings even when taking tirzepatide, its a good idea to discuss this with your healthcare provider, Dr

Eur J Neurosci

It typically settles